Keywordscolorectal cancer; omega-3 fatty acids; immunomodulation; fish oil; leukotrienes; prostate cancer; androgen deprivation therapy; adverse effects; dietary supplements; alternative therapies; breast cancer; inflammation; obesity; adipokines; n-3 polyunsaturated fatty acids; leptin; adiponectin; aromatase; lipid rafts; eicosanoids; enterolactone; lignan; prostate; proliferation; PTEN; miR-106b cluster; n-3 polyunsaturated fatty acids (PUFA); eicosapentaenoic acid (EPA); docosahexaenoic acid (DHA); α-linolenic acid (ALA); mammary gland; breast cancer (BC); adipose tissue; cancer; computed tomography; fat mobilization; risk; progression; survivorship; IGF signaling; saturated fatty acids; monounsaturated fatty acids; polyunsaturated fatty acids; trans fatty acids; DNA damage; Mediterranean style diet; fatty acids; prostate cancer; colorectal cancer; total energy; macronutrient; micronutrients; aging; inflammation; inflammaging; cancer; mediterranean diet; nutrients; microRNAs; NU-AGE project; cancer cachexia; inflammation; white adipose tissue; NF-κB; IκB
